Canagliflozin vs Irbesartan
Canagliflozin vs Irbesartan: Overview
This comparison examines the pharmacological differences between Canagliflozin and Irbesartan.
Mechanism of Action
Canagliflozin: Selective SGLT2 inhibitor reducing renal glucose reabsorption and lowering blood glucose.
Irbesartan: Selective non-competitive angiotensin II type 1 receptor antagonist.
Pharmacokinetics
Half-life: Canagliflozin β 10.6 hours; Irbesartan β 11-15 hours.
Chemical Properties
Molecular Formula: Canagliflozin β C24H25FO5S; Irbesartan β C25H28N6O.
Molecular Weight: Canagliflozin β 444.5170 g/mol; Irbesartan β 428.5320 g/mol.
Type: Canagliflozin β Small molecule; Irbesartan β Small molecule.